Elite Pharmaceuticals Inc (ELTP)

[senderos]

no2: I have been a SH here for about 6 years. It appears to me that the hype and excitement about ELTP's ADT has died and is not considered as important to the bottom line now. The emphasis now would appear to be on the growing portfolio of generics that the company is launching and selling. Am I only imagining this shift in emphasis, which may not be a bad thing at all, or is the ADT value simply sleeping for now, IYO?